Cargando…
Screening of autoantibodies as biomarkers in the serum of renal cancer patients based on human proteome microarray: Screening of autoantibodies in renal cancer
The autoantibody in patients’ serum can act as a biomarker for diagnosing cancer, and the differences in autoantibodies are significantly correlated with the changes in their target proteins. In this study, 16 renal cancer (RC) patients were assigned to the disease group, and 16 healthy people were...
Autores principales: | Sun, Yangyang, Liu, Chengxi, Zhong, Huidong, Wang, Chenguang, Xu, Haibo, Chen, Wei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10157637/ https://www.ncbi.nlm.nih.gov/pubmed/36789694 http://dx.doi.org/10.3724/abbs.2022189 |
Ejemplares similares
-
Generation of Antigen Microarrays to Screen for Autoantibodies in Heart Failure and Heart Transplantation
por: Chruscinski, Andrzej, et al.
Publicado: (2016) -
Autoantibody Profiling on Human Proteome Microarray for Biomarker Discovery in Cerebrospinal Fluid and Sera of Neuropsychiatric Lupus
por: Hu, Chaojun, et al.
Publicado: (2015) -
Use of autoantibodies against tumor-associated antigens as serum biomarkers for primary screening of cervical cancer
por: Jin, Yingji, et al.
Publicado: (2017) -
Human Proteome Microarray identifies autoantibodies to tumor‐associated antigens as serological biomarkers for the diagnosis of hepatocellular carcinoma
por: Yang, Qian, et al.
Publicado: (2023) -
Autoantibody Profiling of Glioma Serum Samples to Identify Biomarkers Using Human Proteome Arrays
por: Syed, Parvez, et al.
Publicado: (2015)